| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 1 | 1 | 1 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 288(4):1027-1031
Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes | 27 | 10
|
| 2 | 1 | 2 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 288(5):1102-1107
Halleux CM; Takahashi M; Delporte ML; Detry R; Funahashi T; Matsuzawa Y; Brichard SM
Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue | 32 | 24
|
| 3 | 1 | 3 2001 FEBS LETTERS 507(2):142-146
Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes | 29 | 20
|
| 4 | 1 | 4 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(41):37731-37734
Rosen ED; Spiegelman BM
PPAR gamma: a nuclear regulator of metabolism, differentiation, and cell growth | 87 | 7
|
| 5 | 1 | 5 2001 JOURNAL OF CLINICAL INVESTIGATION 108(12):1875-1881
Combs TP; Berg AH; Obici S; Scherer PE; Rossetti L
Endogenous glucose production is inhibited by the adipose- derived protein Acrp30 | 54 | 41
|
| 6 | 1 | 6 2001 LANCET 358(9279):390-390
Senior K
Researchers identify an important adipocyte hormone | 0 | 0
|
| 7 | 1 | 7 2001 M S-MEDECINE SCIENCES 17(12):1353-1354
Guerre-Millo M
Leptin kicked out by adiponectin | 1 | 0
|
| 8 | 1 | 8 2001 NATURE 414(6865):799-806
Saltiel AR; Kahn CR
Insulin signalling and the regulation of glucose and lipid metabolism | 136 | 10
|
| 9 | 1 | 9 2001 NATURE 414(6865):821-827
Moller DE
New drug targets for type 2 diabetes and the metabolic syndrome | 42 | 2
|
| 10 | 1 | 10 2001 NATURE MEDICINE 7(8):887-888
Saltiel AR
You are what you secrete | 23 | 11
|
| 11 | 0 | 11 2001 NATURE MEDICINE 7(8):947-953
Berg AH; Combs TP; Du XL; Brownlee M; Scherer P
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action | 178 | 178
|
| 12 | 1 | 12 2002 AMERICAN JOURNAL OF MEDICINE 113():3S-11S
LeRoith D
beta-cell dysfunction and insulin resistance in type 2 diabetes: Role of metabolic and genetic abnormalities | 6 | 0
|
| 13 | 1 | 13 2002 ANNUAL REVIEW OF MEDICINE 53():409-435
Berger J; Moller DE
The mechanisms of action of PPARs | 57 | 1
|
| 14 | 1 | 14 2002 ANNUAL REVIEW OF NUTRITION 22():167-197
Picard F; Auwerx J
PPAR gamma and glucose homeostasis | 16 | 4
|
| 15 | 4 | 15 2002 BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM 16(4):639-651
Prins JB
Adipose tissue as an endocrine organ | 0 | 0
|
| 16 | 1 | 16 2002 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 290(3):1084-1089
Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes | 44 | 26
|
| 17 | 6 | 17 2002 BIOCHEMICAL JOURNAL 367():677-685
Delporte ML; Funahashi T; Takahashi M; Matsuzawa Y; Brichard SM
Pre- and post-translational negative effect of beta- adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies | 10 | 5
|
| 18 | 5 | 18 2002 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 1584(2-3):115-122
Zhang Y; Matheny M; Zolotukhin S; Tumer N; Scarpace PJ
Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta 3-adrenergic agonists, retinoic acid, leptin and fasting | 3 | 2
|
| 19 | 6 | 19 2002 BIOTECHNIQUES 33(3):654-+
Hug C; Lodish HF
Diabetes, obesity, and Acrp30/adiponectin | 0 | 0
|
| 20 | 1 | 20 2002 CLINICAL SCIENCE 103(2):137-142
Yamamoto Y; Hirose H; Saito I; Tomita M; Taniyama M; Matsubara K; Okazaki Y; Ishii T; Nishikai K; Saruta T
Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein- cholesterol, independent of body mass index, in the Japanese population | 14 | 7
|
| 21 | 1 | 21 2002 CURRENT HYPERTENSION REPORTS 4(2):105-111
Rakugi H; Kamide K; Ogihara T
Vascular signaling pathways in the metabolic syndrome | 3 | 0
|
| 22 | 1 | 22 2002 CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE 5(4):359-363
Chen HC; Farese RV
Fatty acids, triglycerides, and glucose metabolism: recent insights from knockout mice | 2 | 1
|
| 23 | 4 | 23 2002 CURRENT OPINION IN LIPIDOLOGY 13(1):51-59
Havel PJ
Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin | 42 | 13
|
| 24 | 3 | 24 2002 CURRENT OPINION IN LIPIDOLOGY 13(3):241-245
Holst D; Grimaldi PA
New factors in the regulation of adipose differentiation and metabolism | 6 | 0
|
| 25 | 5 | 25 2002 CURRENT SCIENCE 83(10):1190-1191
Ehtesham NZ
Does resistin resist insulin? | 2 | 0
|
| 26 | 1 | 26 2002 DEVELOPMENTAL CELL 3(1):25-38
Bluher M; Michael MD; Peroni OD; Ueki K; Carter N; Kahn BB; Kahn CR
Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance | 24 | 3
|
| 27 | 1 | 27 2002 DIABETES 51(5):1319-1336
Ruan H; Hacohen N; Golub TR; Van Parijs L; Lodish HF
Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes - Nuclear factor-kappa B activation by TNF-alpha is obligatory | 17 | 5
|
| 28 | 2 | 28 2002 DIABETES 51(6):1884-1888
Stefan N; Vozarova B; Funahashi T; Matsuzawa Y; Weyer C; Lindsay RS; Youngren JF; Havel PJ; Pratley RE; Bogardus C; Tataranni PA
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans | 25 | 13
|
| 29 | 2 | 29 2002 DIABETES 51(7):2306-2312
Menzaghi C; Ercolino T; Di Paola R; Berg AH; Warram JH; Scherer PE; Trischitta V; Doria A
A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome | 18 | 9
|
| 30 | 2 | 30 2002 DIABETES 51(7):2325-2328
Kondo H; Shimomura I; Matsukawa Y; Kumada M; Takahashi M; Matsuda M; Ouchi N; Kihara S; Kawamoto T; Sumitsuji S; Funahashi T; Matsuzawa Y
Association of adiponectin mutation with type 2 diabetes - A candidate gene for the insulin resistance syndrome | 27 | 14
|
| 31 | 1 | 31 2002 DIABETES 51(8):2467-2473
Karpe F; Fielding BA; Ilic V; Macdonald IA; Summers LKM; Frayn KN
Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity | 1 | 1
|
| 32 | 2 | 32 2002 DIABETES 51(9):2727-2733
Colombo C; Cutson JJ; Yamauchi T; Vinson C; Kadowaki T; Gavrilova O; Reitman ML
Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy | 6 | 3
|
| 33 | 2 | 33 2002 DIABETES 51(9):2734-2741
Nishizawa H; Shimomura H; Kishida K; Maeda N; Kuriyama H; Nagaretani H; Matsuda M; Kondo H; Furuyama N; Kihara S; Nakamura T; Tochino Y; Funahashi T; Matsuzawa Y
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein | 19 | 7
|
| 34 | 4 | 34 2002 DIABETES 51(10):2968-2974
Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects | 21 | 10
|
| 35 | 4 | 35 2002 DIABETES 51(11):3176-3188
Ruan H; Miles PDG; Ladd CM; Ross K; Golub TR; Olefsky JM; Lodish HF
Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha - Implications for insulin resistance | 6 | 1
|
| 36 | 3 | 36 2002 DIABETES 51(11):3189-3195
Chen HC; Stone SJ; Zhou P; Buhman KK; Farese RV
Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme A : diacylglycerol acyltransferase 1 in white adipose tissue | 3 | 0
|
| 37 | 1 | 37 2002 DIABETES CARE 25(2):376-380
Yang WS; Jeng CY; Wu TJ; Tanaka S; Funahashi T; Matsuzawa Y; Wang JP; Chen CL; Tai TY; Chuang LM
Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients | 50 | 22
|
| 38 | 2 | 38 2002 DIABETES CARE 25(9):1665-1666
Imagawa A; Funahashi T; Nakamura T; Moriwaki M; Tanaka S; Nishizawa H; Sayama K; Uno S; Iwahashi H; Yamagata K; Miyagawa JI; Matsuzawa Y
Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes | 6 | 4
|
| 39 | 2 | 39 2002 DIABETOLOGIA 45(9):1201-1210
Frayn KN
Adipose tissue as a buffer for daily lipid flux | 4 | 0
|
| 40 | 2 | 40 2002 DIABETOLOGIA 45(9):1211-1223
Furnsinn C; Waldhausl W
Thiazolidinediones: metabolic actions in vitro | 3 | 0
|
| 41 | 2 | 41 2002 DIABETOLOGIA 45(10):1425-1433
Barth N; Langmann T; Scholmerich J; Schmitz G; Schaffler A
Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways | 3 | 2
|
| 42 | 3 | 42 2002 DISEASE MARKERS 18(2):41-46
Wagner JA
Overview of biomarkers and surrogate endpoints in drug development | 0 | 0
|
| 43 | 1 | 43 2002 DRUGS 62(6):915-944
Fernandez-Lopez JA; Remesar X; Foz M; Alemany M
Pharmacological approaches for the treatment of obesity | 5 | 0
|
| 44 | 1 | 44 2002 ENDOCRINE 18(2):105-119
Alrefai H; Allababidi H; Levy S; Levy J
The endocrine system in diabetes mellitus | 1 | 0
|
| 45 | 1 | 45 2002 ENDOCRINE REVIEWS 23(5):599-622
Evans JL; Goldfine ID; Maddux BA; Grodsky GM
Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes | 17 | 0
|
| 46 | 1 | 46 2002 ENDOCRINOLOGY 143(3):998-1007
Combs TP; Wagner JA; Berger J; Doebber T; Wang WJ; Zhang BB; Tanen M; Berg AH; O'Rahilly S; Savage DB; Chatterjee K; Weiss S; Larson PJ; Gottesdiener KM; Gertz BJ; Charron MJ; Scherer PE; Moller DE
Induction of adipocyte complement-related protein of 30 kilodaltons by PPAR gamma agonists: A potential mechanism of insulin sensitization | 47 | 35
|
| 47 | 1 | 47 2002 ENDOCRINOLOGY 143(4):1502-1511
Xu HY; Hirosumi J; Uysal KT; Guler AD; Hotamisligil GS
Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance | 4 | 0
|
| 48 | 2 | 48 2002 ENDOCRINOLOGY 143(6):2106-2118
Gerhold DL; Liu F; Jiang G; Li Z; Xu J; Lu M; Sachs JR; Bagchi A; Fridman A; Holder DJ; Doebber TW; Berger J; Elbrecht A; Moller DE; Zhang BB
Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists | 11 | 0
|
| 49 | 2 | 49 2002 ENDOCRINOLOGY 143(12):4527-4535
Ye JM; Frangioudakis G; Iglesias MA; Furler SM; Ellis B; Dzamko N; Cooney GJ; Kraegen EW
Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: Role of the liver | 0 | 0
|
| 50 | 4 | 50 2002 EUROPEAN JOURNAL OF ENDOCRINOLOGY 147(4):553-559
Fasshauer M; Klein J; Lossner U; Paschke R
Negative regulation of adipose-expressed galectin-12 by isoproterenol, tumor necrosis factor alpha, insulin and dexamethasone | 1 | 0
|
| 51 | 1 | 51 2002 EUROPEAN JOURNAL OF PHARMACOLOGY 440(2-3):213-221
Tsao TS; Lodish HF; Fruebis J
ACRP30, a new hormone controlling fat and glucose metabolism | 14 | 7
|
| 52 | 9 | 52 2002 HORMONE AND METABOLIC RESEARCH 34(9):469-474
Stefan N; Stumvoll M
Adiponectin - Its role in metabolism and beyond | 7 | 1
|
| 53 | 2 | 53 2002 HORMONE AND METABOLIC RESEARCH 34(10):601-603
Staiger H; Tschritter O; Kausch C; Lammers R; Stumvoll M; Haring HU
Human serum adiponectin levels are not under short-term negative control by free fatty acids in vivo | 1 | 1
|
| 54 | 2 | 54 2002 HORMONE AND METABOLIC RESEARCH 34(11-12):622-628
Atzmon G; Yang XM; Muzumdar R; Ma XH; Gabriely I; Barzilai N
Differential gene expression between visceral and subcutaneous fat depots | 1 | 0
|
| 55 | 3 | 55 2002 HORMONE AND METABOLIC RESEARCH 34(11-12):629-634
Puerta M; Abelenda M; Rocha M; Trayhurn P
Effect of acute cold exposure on the expression of the adiponectin, resistin and leptin genes in rat white and brown adipose tissues | 0 | 0
|
| 56 | 6 | 56 2002 HORMONE AND METABOLIC RESEARCH 34(11-12):640-645
Ott V; Fasshauer M; Dalski A; Meier B; Perwitz N; Klein HH; Tschop M; Klein J
Direct peripheral effects of ghrelin include suppression of adiponectin expression | 1 | 0
|
| 57 | 7 | 57 2002 HORMONE AND METABOLIC RESEARCH 34(11-12):650-654
Fisher FM; McTernan PG; Valsamakis G; Chetty R; Harte AL; Anwar AJ; Starcynski J; Crocker J; Barnett AH; McTernan CL; Kumar S
Differences in adiponectin protein expression: Effect of fat depots and type 2 diabetic status | 1 | 1
|
| 58 | 5 | 58 2002 HUMAN MOLECULAR GENETICS 11(21):2607-2614
Vasseur F; Helbecque N; Dina C; Lobbens S; Delannoy V; Gaget S; Boutin P; Vaxillaire M; Lepretre F; Dupont S; Hara K; Clement K; Bihain B; Kadowaki T; Froguel P
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte- secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians | 12 | 5
|
| 59 | 1 | 59 2002 IMMUNOBIOLOGY 205(4-5):355-364
Kishore U; Kojouharova MS; Reid KBM
Recent progress in the understanding of the structure-function relationships of the globular head regions of C1q | 2 | 0
|
| 60 | 1 | 60 2002 INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 17(4):145-160
Werneke U; Taylor D; Sanders TAB
Options for pharmacological management of obesity in patients treated with atypical antipsychotics | 3 | 0
|
| 61 | 5 | 61 2002 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 31(5):514-520
Mynarcik DC; Combs T; McNurlan MA; Scherer PE; Komaroff E; Gelato MC
Adiponectin and leptin levels in HIV-Infected subjects with insulin resistance and body fat redistribution | 4 | 2
|
| 62 | 1 | 62 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(10):8635-8647
Razani B; Combs TP; Wang XB; Frank PG; Park DS; Russell RG; Li MM; Tang BY; Jelicks LA; Scherer PE; Lisanti MP
Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities | 28 | 1
|
| 63 | 2 | 63 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(15):12503-12506
Forman BM
The antidiabetic agent LG100754 sensitizes cells to low concentrations of peroxisome proliferator-activated receptor gamma ligands | 1 | 0
|
| 64 | 3 | 64 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(22):19521-19529
Wang Y; Xu AM; Knight C; Xu LY; Cooper GJS
Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin - Potential role in the modulation of its insulin-sensitizing activity | 17 | 12
|
| 65 | 1 | 65 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(22):19754-19761
Hartman HB; Hu X; Tyler KX; Dalal CK; Lazar MA
Mechanisms regulating adipocyte expression of resistin | 14 | 2
|
| 66 | 2 | 66 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(29):25863-25866
Kubota N; Terauchi Y; Yamauchi T; Kubota T; Moroi M; Matsui J; Eto K; Yamashita T; Kamon J; Satoh H; Yano W; Froguel P; Nagai R; Kimura S; Kadowaki T; Noda T
Disruption of adiponectin causes insulin resistance and neointimal formation. | 51 | 28
|
| 67 | 6 | 67 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(38):34658-34661
Ma K; Cabrero A; Saha PK; Kojima H; Li L; Chang BHJ; Paul A; Chan L
Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin | 14 | 6
|
| 68 | 3 | 68 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(40):37487-37491
Matsuda M; Shimomura I; Sata M; Arita Y; Nishida M; Maeda N; Kumada M; Okamoto Y; Nagaretani H; Nishizawa H; Kishida K; Komuro R; Ouchi N; Kihara S; Nagai R; Funahashi T; Matsuzawa Y
Role of adiponectin in preventing vascular stenosis - The missing link of adipo-vascular axis | 19 | 8
|
| 69 | 1 | 69 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(44):42011-42016
Blagoev B; Kratchmarova I; Nielsen MM; Fernandez MM; Voldby J; Andersen JS; Kristiansen K; Pandey A; Mann M
Inhibition of adipocyte differentiation by resistin-like molecule alpha - Biochemical characterization of its oligomeric nature | 7 | 2
|
| 70 | 1 | 70 2002 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 87(5):2395-2398
Haque WA; Shimomura I; Matsuzawa Y; Garg A
Serum adiponectin and leptin levels in patients with lipodystrophies | 29 | 10
|
| 71 | 4 | 71 2002 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 87(10):4652-4656
Stefan N; Bunt JC; Salbe AD; Funahashi T; Matsuzawa Y; Tataranni PA
Plasma adiponectin concentrations in children: Relationships with obesity and insulinemia | 8 | 3
|
| 72 | 4 | 72 2002 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 87(12):5362-5366
Wagner JA
Early clinical development of pharmaceuticals for type 2 diabetes mellitus: From preclinical models to human investigation | 0 | 0
|
| 73 | 6 | 73 2002 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 87(12):5662-5667
Motoshima H; Wu XD; Sinha MK; Hardy VE; Rosato EL; Barbot DJ; Rosato FE; Goldstein BJ
Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone | 4 | 1
|
| 74 | 1 | 74 2002 JOURNAL OF CLINICAL INVESTIGATION 109(8):1049-1055
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV
Increased insulin and leptin sensitivity in mice lacking acyl CoA : diacylglycerol acyltransferase 1 | 14 | 2
|
| 75 | 1 | 75 2002 JOURNAL OF CLINICAL INVESTIGATION 109(10):1303-1310
Yokota T; Meka CSR; Medina KL; Igarashi H; Comp PC; Takahashi M; Nishida M; Oritani K; Miyagawa J; Funahashi T; Tomiyama Y; Matsuzawa Y; Kincade PW
Paracine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins | 5 | 2
|
| 76 | 11 | 76 2002 JOURNAL OF MOLECULAR MEDICINE-JMM 80(11):696-702
Ukkola O; Santaniemi M
Adiponectin: a link between excess adiposity and associated comorbidities? | 2 | 0
|
| 77 | 2 | 77 2002 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 40(4):652-661
Marso SP
Optimizing the diabetic formulary: Beyond aspirin and insulin | 2 | 0
|
| 78 | 1 | 78 2002 LIPIDS AND INSULIN RESISTANCE: THE ROLE OF FATTY ACID METABOLISM AND FUEL PARTITIONING 967():363-378
Ravussin E; Smith SR
Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus | 20 | 7
|
| 79 | 1 | 79 2002 MEDICINA CLINICA 118(16):619-621
Escofet FJS; Martinez GR
The irresistible ascent of the adipose cell | 0 | 0
|
| 80 | 1 | 80 2002 METABOLISM-CLINICAL AND EXPERIMENTAL 51(11):1407-1409
Yamamoto Y; Hirose H; Miyashita K; Nishikai K; Saito I; Taniyama M; Tomita M; Saruta T
PPAR gamma 2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population | 3 | 1
|
| 81 | 2 | 81 2002 MICROSCOPY RESEARCH AND TECHNIQUE 59(4):317-324
Chiba T; Yamaza H; Higami Y; Shimokawa I
Anti-aging effects of caloric restriction: Involvement of neuroendocrine adaptation by peripheral signaling | 1 | 0
|
| 82 | 1 | 82 2002 MOLECULAR AND CELLULAR BIOLOGY 22(16):5989-5999
Ross SE; Erickson RL; Gerin I; DeRose PM; Bajnok L; Longo KA; Misek DE; Kuick R; Hanash SM; Atkins KB; Andresen SM; Nebb HI; Madsen L; Kristiansen K; MacDougald OA
Microarray analyses during adipogenesis: Understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism | 12 | 0
|
| 83 | 2 | 83 2002 MOLECULAR ENDOCRINOLOGY 16(8):1920-1930
Rajala MW; Lin Y; Ranalletta M; Yang XM; Qian H; Gingerich R; Barzilai N; Scherer PE
Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue | 9 | 1
|
| 84 | 2 | 84 2002 NATURE 420(6913):333-336
Hirosumi J; Tuncman G; Chang LF; Gorgun CZ; Uysal KT; Maeda K; Karin M; Hotamisligil GS
A central role for JNK in obesity and insulin resistance | 28 | 2
|
| 85 | 1 | 85 2002 NATURE GENETICS 30(2):221-226
Yamauchi T; Oike Y; Kamon J; Waki H; Komeda K; Tsuchida A; Date Y; Li MX; Miki H; Akanuma Y; Nagai R; Kimura S; Saheki T; Nakazato M; Naitoh T; Yamamura K; Kadowaki T
Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice | 9 | 4
|
| 86 | 6 | 86 2002 NATURE MEDICINE 8(7):731-737
Maeda N; Shimomura I; Kishida K; Nishizawa H; Matsuda M; Nagaretani H; Furuyama N; Kondo H; Takahashi M; Arita Y; Komuro R; Ouchi N; Kihara S; Tochino Y; Okutomi K; Horie M; Takeda S; Aoyama T; Funahashi T; Matsuzawa Y
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 | 70 | 35
|
| 87 | 2 | 87 2002 NATURE MEDICINE 8(11):1288-1295
Yamauchi T; Kamon J; Minokoshi Y; Ito Y; Waki H; Uchida S; Yamashita S; Noda M; Kita S; Ueki K; Eto K; Akanuma Y; Froguel P; Foufelle F; Ferre P; Carling D; Kimura S; Nagai R; Kahn BB; Kadowaki T
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | 37 | 18
|
| 88 | 1 | 88 2002 NEW ENGLAND JOURNAL OF MEDICINE 346(8):570-578
Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
Leptin-replacement therapy for lipodystrophy | 77 | 10
|
| 89 | 4 | 89 2002 OBESITY RESEARCH 10(11):1095-1103
Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R
Resistin and adiponectin expression in visceral fat of obese rats: Effect of weight loss | 6 | 1
|
| 90 | 6 | 90 2002 OBESITY RESEARCH 10(11):1104-1110
Yang WS; Lee WJ; Funahashi T; Tanaka S; Matsuzawa Y; Chao CL; Chen CL; Tai TY; Chuang LM
Plasma adiponectin levels in overweight and obese Asians | 5 | 3
|
| 91 | 8 | 91 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(25):16309-16313
Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang CC; Itani SI; Lodish HF; Ruderman NB
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP- activated protein kinase activation | 11 | 6
|
| 92 | 1 | 92 2002 REGULATORY PEPTIDES 109(1-3):173-179
Innamorati G; Whang MI; Molteni R; Le Gouill C; Birnbaumer M
GIP, a G-protein-coupled receptor interacting protein | 0 | 0
|
| 93 | 1 | 93 2002 TRENDS IN ENDOCRINOLOGY AND METABOLISM 13(1):18-23
Steppan CM; Lazar MA
Resistin and obesity-associated insulin resistance | 46 | 12
|
| 94 | 1 | 94 2002 TRENDS IN ENDOCRINOLOGY AND METABOLISM 13(2):84-89
Berg AH; Combs TP; Scherer PE
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism | 54 | 31
|
| 95 | 4 | 95 2002 TRENDS IN MOLECULAR MEDICINE 8(9):442-447
Camp HS; Ren DL; Leff T
Adipogenesis and fat-cell function in obesity and diabetes | 1 | 0
|
| 96 | 1 | 96 2003 ACTA PHYSIOLOGICA SCANDINAVICA 178(4):373-383
Hegarty BD; Furler SM; Ye J; Cooney GJ; Kraegen EW
The role of intramuscular lipid in insulin resistance | 0 | 0
|
| 97 | 3 | 97 2003 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 284(2):E443-E448
Lihn AS; Ostergard T; Nyholm B; Pedersen SB; Richelsen B; Schmitz O
Adiponectin expression in adipose tissue is reduced in first- degree relatives of type 2 diabetic patients | 3 | 3
|
| 98 | 3 | 98 2003 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 284(3):E531-E540
Ye JM; Iglesias MA; Watson DG; Ellis B; Wood L; Jensen PB; Sorensen RV; Larsen PJ; Cooney GJ; Wassermann K; Kraegen EW
PPAR alpha/gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly | 7 | 1
|
| 99 | 5 | 99 2003 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 285(3):E527-E533
Bruun JM; Lihn AS; Verdich C; Pedersen SB; Toubro S; Astrup A; Richelsen B
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans | 1 | 1
|
| 100 | 15 | 100 2003 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 285(5):E1072-E1080
Lihn AS; Richelsen B; Pedersen SB; Haugaard SB; Rathje GS; Madsbad S; Andersen O
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels | 0 | 0
|
| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 101 | 1 | 101 2003 ANNUAL REVIEW OF PHYSIOLOGY 65():261-311
Francis GA; Fayard E; Picard F; Auwerx J
Nuclear receptors and the control of metabolism | 8 | 0
|
| 102 | 6 | 102 2003 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 416(2):164-170
Maebuchi M; Machidori M; Urade R; Ogawa T; Moriyama T
Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin | 0 | 0
|
| 103 | 8 | 103 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 301(4):1045-1050
Fasshauer M; Kralisch S; Klier M; Lossner U; Bluher M; Klein J; Paschke R
Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes | 4 | 3
|
| 104 | 3 | 104 2003 CELL 113(2):159-170
Wang YX; Lee CH; Tiep S; Yu RT; Ham JY; Kang HJ; Evans RM
Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity | 5 | 0
|
| 105 | 4 | 105 2003 CLINICAL CHEMISTRY 49(4):650-652
Pischon T; Hotamisligil GS; Rimm EB
Adiponectin: Stability in plasma over 36 hours and within- person variation over 1 year | 0 | 0
|
| 106 | 8 | 106 2003 CLINICAL ENDOCRINOLOGY 58(1):22-29
Delporte ML; Brichard SM; Hermans MP; Beguin C; Lambert M
Hyperadiponectinaemia in anorexia nervosa | 1 | 1
|
| 107 | 4 | 107 2003 CLINICAL ENDOCRINOLOGY 59(3):267-277
Gurnell M
PPAR gamma and metabolism: insights from the study of human genetic variants | 0 | 0
|
| 108 | 2 | 108 2003 CURRENT MOLECULAR MEDICINE 3(2):107-125
Cederberg A; Enerback S
Insulin resistance and type 2 diabetes - An adipocentric view | 0 | 0
|
| 109 | 21 | 109 2003 CURRENT PHARMACEUTICAL DESIGN 9(17):1411-1418
Heilbronn LK; Smith SR; Ravissin E
The insulin-sensitizing role of the fat derived hormone adiponectin | 0 | 0
|
| 110 | 13 | 110 2003 CYTOKINE & GROWTH FACTOR REVIEWS 14(5):447-455
Ruan H; Lodish HF
Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha | 0 | 0
|
| 111 | 6 | 111 2003 DIABETES 52(2):268-276
Combs TP; Berg AH; Rajala MW; Klebanov S; Iyengar P; Jimenez-Chillaron JC; Patti ME; Klein SL; Weinstein RS; Scherer PE
Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin | 5 | 3
|
| 112 | 7 | 112 2003 DIABETES 52(3):667-674
Phillips SA; Ciaraldi TP; Kong APS; Bandukwala R; Aroda V; Carter L; Baxi S; Mudaliar SR; Henry RR
Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy | 3 | 1
|
| 113 | 4 | 113 2003 DIABETES 52(4):910-917
Savage DB; Tan GD; Acerini CL; Jebb SA; Agostini M; Gurnell M; Williams RL; Umpleby AM; Thomas EL; Bell JD; Dixon AK; Dunne F; Boiani R; Cinti S; Vidal-Puig A; Karpe F; Chatterjee VKK; Rahilly S
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator- activated receptor-gamma | 3 | 1
|
| 114 | 14 | 114 2003 DIABETES 52(4):942-947
Engeli S; Feldpausch M; Gorzelniak K; Hartwig G; Heintze U; Janke J; Mohlig M; Pfeiffer AFH; Luft FC; Sharma AM
Association between adiponectin and mediators of inflammation in obese women | 2 | 1
|
| 115 | 11 | 115 2003 DIABETES 52(5):1182-1186
Pellme F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients | 1 | 0
|
| 116 | 12 | 116 2003 DIABETES 52(6):1355-1363
Wu XD; Motoshima H; Mahadev K; Stalker TJ; Scalia R; Goldstein BJ
Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes | 0 | 0
|
| 117 | 9 | 117 2003 DIABETES 52(7):1655-1663
Iwaki M; Matsuda M; Maeda N; Funahashi T; Matsuzawa Y; Makishima M; Shimomura I
Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors | 0 | 0
|
| 118 | 7 | 118 2003 DIABETES 52(7):1779-1785
Kern PA; Di Gregorio GB; Lu T; Rassouli N; Ranganathan G
Adiponectin expression from human adipose tissue - Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression | 0 | 0
|
| 119 | 1 | 119 2003 DIABETES 52(7):1864-1871
Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
A functional variant in the peroxisome proliferator-activated receptor gamma 2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians | 0 | 0
|
| 120 | 7 | 120 2003 DIABETES 52(9):2266-2273
Masaki T; Chiba S; Yasuda T; Tsubone T; Kakuma T; Shimomura I; Funahashi T; Matsuzawa Y; Yoshimatsu H
Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (A(y)/a) obese mice | 0 | 0
|
| 121 | 7 | 121 2003 DIABETES 52(9):2419-2425
Lindsay RS; Funahashi T; Krakoff J; Matsuzawa Y; Tanaka S; Kobes S; Bennett PH; Tataranni PA; Knowler WC; Hanson RL
Genome-wide linkage analysis of serum adiponectin in the Pima Indian population | 0 | 0
|
| 122 | 2 | 122 2003 DIABETES 52(10):2453-2460
Kim SP; Ellmerer M; Van Citters GW; Bergman RN
Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog | 0 | 0
|
| 123 | 7 | 123 2003 DIABETES CARE 26(7):2015-2020
Daimon M; Oizumi T; Saitoh T; Kameda W; Hirata A; Yamaguchi H; Ohnuma H; Igarashi M; Tominaga M; Kato T
Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population - The Funagata study | 0 | 0
|
| 124 | 7 | 124 2003 DIABETES CARE 26(8):2244-2249
Lindsay RS; Walker JD; Havel PJ; Hamilton BA; Calder AA; Johnstone FD; Scottish Multicentre Study Diabet
Adiponectin is present in cord blood but is unrelated to birth weight | 0 | 0
|
| 125 | 21 | 125 2003 DIABETES CARE 26(8):2442-2450
Chandran M; Phillips SA; Ciaraldi T; Henry RR
Adiponectin: More than just another fat cell hormone? | 0 | 0
|
| 126 | 3 | 126 2003 DIABETES OBESITY & METABOLISM 5(2):131-135
Valsamakis G; Chetty R; McTernan PG; Al-Daghri NM; Barnett AH; Kumar S
Fasting serum adiponectin concentration is reduced in Indo- Asian subjects and is related to HDL cholesterol | 1 | 1
|
| 127 | 1 | 127 2003 DIABETOLOGIA 46(7):R43-R45
Carvalho E
EFSD/Eli Lilly research fellowship in diabetes & metabolism | 0 | 0
|
| 128 | 10 | 128 2003 DIABETOLOGIA 46(4):459-469
Cnop M; Havel PJ; Utzschneider KM; Carr DB; Sinha MK; Boyko EJ; Retzlaff BM; Knopp RH; Brunzell JD; Kahn SE
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex | 1 | 1
|
| 129 | 9 | 129 2003 DIABETOLOGIA 46(7):956-960
Staiger H; Kausch C; Guirguis A; Weisser M; Maerker E; Stumvoll M; Lammers R; Machicao F; Haring HU
Induction of adiponectin gene expression in human myotubes by an adiponectin-containing HEK293 cell culture supernatant | 0 | 0
|
| 130 | 9 | 130 2003 DIABETOLOGIA 46(7):977-983
Yang WS; Hsiung CA; Ho LT; Chen YT; He CT; Curb JD; Grove J; Quertermous T; Chen YDI; Kuo SS; Chuang LM; Sapphire Study Grp
Genetic epistasis of adiponectin and PPAR gamma 2 genotypes in modulation of insulin sensitivity: a family-based association study | 0 | 0
|
| 131 | 1 | 131 2003 ENDOCRINE 20(3):239-245
Piermaria J; Console G; Perello M; Moreno G; Gaillard RC; Spinedi E
Impact of estradiol on parametrial adipose tissue function - Evidence for establishment of a new set point of leptin sensitivity in control of energy metabolism in female rat | 1 | 0
|
| 132 | 5 | 132 2003 ENDOCRINOLOGY 144(2):500-508
Chen L; Nyomba BLG
Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: Modulation by postnatal high-fat diet | 0 | 0
|
| 133 | 1 | 133 2003 ENDOCRINOLOGY 144(4):1585-1593
Roy SS; Mukherjee M; Bhattacharya S; Mandal CN; Kumar LR; Dasgupta S; Bandyopadhyay I; Wakabayashi K
A new cell secreting insulin | 0 | 0
|
| 134 | 2 | 134 2003 ENDOCRINOLOGY 144(6):2201-2207
Lee CH; Olson P; Evans RM
Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors | 2 | 0
|
| 135 | 15 | 135 2003 ENDOCRINOLOGY 144(9):3765-3773
Rajala MW; Scherer PE
Minireview: The adipocyte - At the crossroads of energy homeostasis, inflammation, and atherosclerosis | 1 | 0
|
| 136 | 28 | 136 2003 EUROPEAN JOURNAL OF ENDOCRINOLOGY 148(3):293-300
Diez JJ; Iglesias P
The role of the novel adipocyte-derived hormone adiponectin in human disease | 3 | 1
|
| 137 | 5 | 137 2003 EUROPEAN JOURNAL OF ENDOCRINOLOGY 148(3):343-350
Matsubara M; Katayose S; Maruoka S
Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios | 0 | 0
|
| 138 | 2 | 138 2003 EUROPEAN JOURNAL OF ENDOCRINOLOGY 149(3):231-238
Li Y; Totsune K; Takeda K; Furuyama K; Shibahara S; Takahashi K
Differential expression of adrenomedullin and resistin in 3T3- L1 adipocytes treated with tumor necrosis factor-alpha | 0 | 0
|
| 139 | 2 | 139 2003 HEPATOLOGY 37(5):1202-1219
Neuschwander-Tetri BA; Caldwell SH
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | 2 | 0
|
| 140 | 6 | 140 2003 HORMONE AND METABOLIC RESEARCH 35(3):147-152
Fasshauer M; Klein J; Lossner U; Paschke R
Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes | 0 | 0
|
| 141 | 17 | 141 2003 HORMONE AND METABOLIC RESEARCH 35(6):337-342
Brichard SM; Delporte ML; Lambert M
Adipocytokines in anorexia nervosa: A review focusing on leptin and adiponectin | 0 | 0
|
| 142 | 1 | 142 2003 HYPERTENSION 41(5):1047-1055
Pausova Z; Sedova L; Berube J; Hamet P; Tremblay J; Dumont M; Gaudet D; Pravenec M; Kren V; Kunes J
Segment of rat chromosome 20 regulates diet-induced augmentations in adiposity, glucose intolerance, and blood pressure | 0 | 0
|
| 143 | 6 | 143 2003 HYPERTENSION 42(1):76-81
Furuhashi M; Ura N; Higashiura K; Murakami H; Tanaka M; Moniwa N; Yoshida D; Shimamoto K
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension | 0 | 0
|
| 144 | 2 | 144 2003 INTERNATIONAL JOURNAL OF OBESITY 27(6):657-662
Peake PW; Kriketos AD; Denyer GS; Campbell LV; Charlesworth JA
The postprandial response of adiponectin to a high-fat meal in normal and insulin-resistant subjects | 0 | 0
|
| 145 | 2 | 145 2003 INTERNATIONAL JOURNAL OF OBESITY 27(8):875-888
Frayn KN; Karpe F; Fielding BA; Macdonald IA; Coppack SW
Integrative physiology of human adipose tissue | 0 | 0
|
| 146 | 5 | 146 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(4):2461-2468
Yamauchi T; Kamon J; Waki H; Imai Y; Shimozawa N; Hioki K; Uchida S; Ito Y; Takakuwa K; Matsui J; Takata M; Eto K; Terauchi Y; Komeda K; Tsunoda M; Murakami K; Ohnishi Y; Naitoh T; Yamamura K; Ueyama Y; Froguel P; Kimura S; Nagai R; Kadowaki T
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis | 10 | 5
|
| 147 | 4 | 147 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(6):3992-3999
Colombo C; Haluzik M; Cutson JJ; Dietz KR; Marcus-Samuels B; Vinson C; Gavrilova O; Reitman ML
Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice | 1 | 0
|
| 148 | 5 | 148 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(11):9073-9085
Pajvani UB; Du XL; Combs TP; Berg AH; Rajala MW; Schulthess T; Engel J; Brownlee M; Scherer PE
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin - Implications for metabolic regulation and bioactivity | 4 | 3
|
| 149 | 8 | 149 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(41):40352-40363
Waki H; Yamauchi T; Kamon J; Ito Y; Uchida S; Kita S; Hara K; Hada Y; Vasseur F; Froguel P; Kimura S; Nagai R; Kadowaki T
Impaired multimerization of human adiponectin mutants associated with diabetes - Molecular structure and multimer formation of adiponectin | 0 | 0
|
| 150 | 2 | 150 2003 JOURNAL OF CELLULAR BIOCHEMISTRY 89(1):38-47
Wang MH; Tafuri S
Modulation of PPAR gamma activity with pharmaceutical agents: Treatment of insulin resistance and atherosclerosis | 1 | 0
|
| 151 | 6 | 151 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(2):627-636
Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy | 5 | 1
|
| 152 | 9 | 152 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(4):1559-1564
Tong Q; Sankale JL; Hadigan CM; Tan G; Rosenberg ES; Kanki PJ; Grinspoon SK; Hotamisligil GS
Regulation of adiponectin in human immunodeficiency virus- infected patients: Relationship to body composition and metabolic indices | 1 | 1
|
| 153 | 2 | 153 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(4):1730-1736
Yannakoulia M; Yiannakouris N; Bluher S; Matalas AL; Klimis-Zacas D; Mantzoros CS
Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans | 1 | 0
|
| 154 | 11 | 154 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(4):1907-1910
Sutinen J; Korsheninnikova E; Funahashi T; Matsuzawa Y; Nyman T; Yki-Jarvinen H
Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with active antiretroviral therapy-associated lipodystrophy | 1 | 1
|
| 155 | 5 | 155 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(6):2412-2421
Gurnell M; Savage DB; Chatterjee VKK; O'Rahilly S
The metabolic syndrome: Peroxisome proliferator-activated receptor gamma and its therapeutic modulation | 1 | 0
|
| 156 | 9 | 156 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(6):2714-2718
Fernandez-Real JM; Lopez-Bermejo A; Casamitjana R; Ricart W
Novel interactions of adiponectin with the endocrine system and inflammatory parameters | 0 | 0
|
| 157 | 12 | 157 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(9):4130-4134
Huang KC; Chen CL; Chuang LM; Ho SR; Tai TY; Yang WS
Plasma adiponectin levels and blood pressures in nondiabetic adolescent females | 0 | 0
|
| 158 | 2 | 158 2003 JOURNAL OF CLINICAL INVESTIGATION 111(2):225-230
Rajala MW; Obici S; Scherer PE; Rossetti L
Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production | 9 | 2
|
| 159 | 5 | 159 2003 JOURNAL OF CLINICAL INVESTIGATION 111(11):1715-1722
Chen HC; Jensen DR; Myers HM; Eckel RH; Farese RV
Obesity resistance and enhanced glucose metabolism in mice transplanted with white adipose tissue lacking acyl CoA : diacylglycerol acyltransferase 1 | 0 | 0
|
| 160 | 12 | 160 2003 JOURNAL OF CLINICAL INVESTIGATION 112(1):91-100
Xu AM; Wang Y; Keshaw H; Xu LY; Lam KSL; Cooper GJS
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice | 0 | 0
|
| 161 | 3 | 161 2003 JOURNAL OF CLINICAL INVESTIGATION 112(4):608-618
Norris AW; Chen LH; Fisher SJ; Szanto I; Ristow M; Jozsi AC; Hirshman MF; Rosen ED; Goodyear LJ; Gonzalez FJ; Spiegelman BM; Kahn CR
Muscle-specific PPAR gamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones | 0 | 0
|
| 162 | 10 | 162 2003 JOURNAL OF MOLECULAR MEDICINE-JMM 81(4):218-226
Banerjee RR; Lazar MA
Resistin: molecular history and prognosis | 1 | 0
|
| 163 | 4 | 163 2003 JOURNAL OF MOLECULAR MEDICINE-JMM 81(7):428-434
Yang WS; Tsou PL; Lee WJ; Tseng DL; Chen CL; Peng CC; Lee KC; Chen MJ; Huang CJ; Tai TY; Chuang LM
Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity | 0 | 0
|
| 164 | 2 | 164 2003 JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY 59(1):51-60
Fortuno A; Rodriguez A; Gomez-Ambrosi J; Fruhbeck G; Diez J
Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases | 0 | 0
|
| 165 | 1 | 165 2003 LANCET 361(9353):226-228
Spranger J; Kroke A; Mohling M; Bergmann MM; Ristow M; Boeing H; Pfeiffer AFH
Adiponectin and protection against type 2 diabetes mellitus | 9 | 4
|
| 166 | 2 | 166 2003 MAYO CLINIC PROCEEDINGS 78(4):447-456
Gerich JE
Contributions of insulin-resistance and insulin-secretory defects to the pathognesis of type 2 diabetes mellitus | 2 | 0
|
| 167 | 3 | 167 2003 METABOLISM-CLINICAL AND EXPERIMENTAL 52(6):778-783
Tschritter O; Fritsche A; Stefan N; Haap M; Thamer C; Bachmann O; Dahl D; Maerker E; Teigeler A; Machicao F; Haring H; Stumvoll M
Increased insulin clearance in peroxisome proliferator- activated receptor gamma(2) Pro12Ala | 0 | 0
|
| 168 | 11 | 168 2003 METABOLISM-CLINICAL AND EXPERIMENTAL 52(8):958-963
Altomonte J; Harbaran S; Richter A; Dong HJ
Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats | 0 | 0
|
| 169 | 2 | 169 2003 METABOLISM-CLINICAL AND EXPERIMENTAL 52(9):1113-1116
Kazumi T; Kawaguchi A; Hirano T; Yoshino G
C-reactive protein in young, apparently healthy men: Associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol | 0 | 0
|
| 170 | 1 | 170 2003 MOLECULAR AND CELLULAR BIOLOGY 23(4):1428-1440
Holler N; Tardivel A; Kovacsovics-Bankowski M; Hertig S; Gaide O; Martinon F; Tinel A; Deperthes D; Calderara S; Schulthess T; Engel J; Schneider P; Tschopp E
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex | 2 | 0
|
| 171 | 3 | 171 2003 MOLECULAR AND CELLULAR BIOLOGY 23(17):6159-6173
Wang CG; Pattabiraman N; Zhou JN; Fu MF; Sakamaki T; Albanese C; Li ZP; Wu KM; Hulit J; Neumeister P; Novikoff PM; Brownlee M; Scherer PE; Jones JG; Whitney KD; Donehower LA; Harris EL; Rohan T; Johns DC; Pestell RG
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation | 0 | 0
|
| 172 | 6 | 172 2003 MOLECULAR ENDOCRINOLOGY 17(8):1522-1533
Seo JB; Noh MJ; Yoo EJ; Park SY; Park J; Lee IK; Park SD; Kim JB
Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha | 1 | 1
|
| 173 | 2 | 173 2003 MOLECULAR PHARMACOLOGY 63(4):908-914
Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrie P
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells | 0 | 0
|
| 174 | 6 | 174 2003 NATURE 423(6941):762-769
Yamauchi T; Kamon J; Ito Y; Tsuchida A; Yokomizo T; Kita S; Sugiyama T; Miyagishi M; Hara K; Tsunoda M; Murakami K; Ohteki T; Uchida S; Takekawa S; Waki H; Tsuno NH; Shibata Y; Terauchi Y; Froguel P; Tobe K; Koyasu S; Taira K; Kitamura T; Shimizu T; Nagai R; Kadowaki T
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | 3 | 0
|
| 175 | 11 | 175 2003 NETHERLANDS JOURNAL OF MEDICINE 61(6):194-212
Jazet IM; Pijl H; Meinders AE
Adipose tissue as an endocrine organ: impact on insulin resistance | 0 | 0
|
| 176 | 1 | 176 2003 OBESITY RESEARCH 11(9):1048-1054
Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance | 0 | 0
|
| 177 | 2 | 177 2003 OCL-OLEAGINEUX CORPS GRAS LIPIDES 10(2):131-134
Aubert R
New molecules implied in obesity and insulinoresistance: adipokines | 0 | 0
|
| 178 | 1 | 178 2003 ONCOGENE 22(41):6408-6423
Iyengar P; Combs TP; Shah SJ; Gouon-Evans V; Pollard JW; Albanese C; Flanagan L; Tenniswood MP; Guha C; Lisanti MP; Pestell RG; Scherer PE
Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization | 0 | 0
|
| 179 | 3 | 179 2003 TRENDS IN ENDOCRINOLOGY AND METABOLISM 14(4):169-175
Morral N
Novel targets and therapeutic strategies for type 2 diabetes | 0 | 0
|